• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diabetic retinopathy. Background, classification, pathophysiology.

作者信息

Mames R N

机构信息

Retina Center, Gainesville 32605.

出版信息

J Fla Med Assoc. 1994 Apr;81(4):240-2.

PMID:8046361
Abstract

Diabetic retinopathy is the leading cause of legal blindness in the working adult population of the United States. The longer the duration of diabetes, the greater the likelihood retinopathy will develop. The proper classification of retinopathy is critical to the appropriate choice of therapeutic intervention and to the frequency of follow-up office visits. Monitoring of the patient must be a cooperative, team approach and requires early referral to an ophthalmologist experienced in the care of diabetics. The mainstay of current treatment is prevention through improved glucose control, early detection and, when necessary, intervention with timely laser photocoagulation and/or vitrectomy surgery. Based upon increased knowledge of the pathophysiology of diabetic retinopathy, the future may hold the ability to treat it with biological interventions at an earlier point in the course of the disease.

摘要

相似文献

1
Diabetic retinopathy. Background, classification, pathophysiology.
J Fla Med Assoc. 1994 Apr;81(4):240-2.
2
Managing diabetic retinopathy: the partnership between ophthalmologist and primary care physician.糖尿病视网膜病变的管理:眼科医生与初级保健医生之间的合作关系
J Miss State Med Assoc. 1995 Jul;36(7):201-8.
3
Diabetic retinopathy: management update.糖尿病视网膜病变:管理更新
Niger Postgrad Med J. 2003 Jun;10(2):115-20.
4
Pharmacological approach to diabetic retinopathy.糖尿病视网膜病变的药理学治疗方法。
Diabetes Metab Res Rev. 2004 Mar-Apr;20(2):91-113. doi: 10.1002/dmrr.432.
5
[Ocular complications in diabetes: towards standardizing screening and care].[糖尿病的眼部并发症:迈向筛查与护理的标准化]
Rev Prat. 2001 Oct 15;51(16):1776-82.
6
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.糖尿病性视网膜病变。失明的筛查与预防。博士论文。
Acta Ophthalmol Scand Suppl. 1997(223):1-76.
7
Diabetic retinopathy: update on therapeutic advances.
Geriatrics. 1980 Sep;35(9):67-9, 72-3.
8
[Diabetic retinopathy. Current opinion on pathophysiology, diagnostics and therapy].[糖尿病视网膜病变。关于病理生理学、诊断和治疗的当前观点]
Przegl Lek. 2005;62(4):238-42.
9
Somatostatin in diabetic retinopathy.糖尿病视网膜病变中的生长抑素。
Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:518-24.
10
[Early diagnosis and therapy of diabetic retinopathy].[糖尿病视网膜病变的早期诊断与治疗]
Ther Umsch. 1996 Dec;53(12):934-42.

引用本文的文献

1
Distribution of diabetic retinopathy in diabetes mellitus patients and its association rules with other eye diseases.糖尿病患者中糖尿病视网膜病变的分布及其与其他眼部疾病的关联规则。
Sci Rep. 2021 Aug 20;11(1):16993. doi: 10.1038/s41598-021-96438-w.
2
MiRNA-144-3p inhibits high glucose induced cell proliferation through suppressing FGF16.miRNA-144-3p 通过抑制 FGF16 抑制高糖诱导的细胞增殖。
Biosci Rep. 2019 Jul 25;39(7). doi: 10.1042/BSR20181788. Print 2019 Jul 31.